Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
21.99
-0.01 (-0.05%)
Jul 25, 2025, 4:00 PM - Market closed

Company Description

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.

The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older.

It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025.

Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.

Pelthos Therapeutics Inc.
Pelthos Therapeutics logo
CountryUnited States
Founded2002
IndustryBiotechnology
SectorHealthcare
Employees11
CEOScott Plesha

Contact Details

Address:
4020 Stirrup Creek Drive, Suite 110
Durham, North Carolina 27703
United States
Phone877 265 8266
Websitechanneltherapeutics.com

Stock Details

Ticker SymbolPTHS
ExchangeNYSEAMERICAN
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001919246
ISIN NumberUS1711261057
Employer ID86-3335449
SIC Code2836

Key Executives

NamePosition
Scott PleshaChief Executive Officer

Latest SEC Filings

DateTypeTitle
Jul 10, 2025DNotice of Exempt Offering of Securities
Jul 8, 2025SCHEDULE 13GFiling
Jul 3, 2025SCHEDULE 13D/AFiling
Jul 3, 2025SCHEDULE 13DFiling
Jul 2, 20258-KCurrent Report
May 27, 2025DEFM14CFiling
May 13, 202510-QQuarterly Report
May 9, 2025PREM14CFiling
May 1, 20258-KCurrent Report
Apr 17, 20258-KCurrent Report